Pear Therapeutics, Inc.: income_tax_expense
| Value | {"amount": 0, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-03-31 |
| Status | current |
| Entity | Pear Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/02e339b9-b809-4b27-803f-8093bf71c4a0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-170643 · Open the official SEC filing →Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001835567/income-tax-expense/2021-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/02e339b9-b809-4b27-803f-8093bf71c4a0
History
- no predecessors — first report